Aberrant Melan-A expression in atypical fibroxanthoma and undifferentiated pleomorphic sarcoma of the skin

Journal of Cutaneous Pathology

Volumn 38, Issue 12, 2011, Pages 954-960

  Thum, Chee ^a   Hollowood, Kevin ^b   Birch, Jeremy ^b   Goodlad, John R ^a   Brenn, Thomas ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

immunocytochemistry; MART 1; Melan A; melanoma; soft tissue tumors

Indexed keywords

MELAN A;

AGED; ARTICLE; BIOSYNTHESIS; CASE REPORT; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; FIBROMA; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; PATHOLOGY; SKIN TUMOR; XANTHOMATOSIS;

AGED; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FIBROMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MART-1 ANTIGEN; SKIN NEOPLASMS; XANTHOMATOSIS;

EID: 80755144059     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01798.x     Document Type: Article

References (24)

1. Beer TW, Drury P, Heenan PJ., Atypical fibroxanthoma: a histological and immunohistochemical review of 171 Cases. Am J Dermatopathol 2010; 32: 533.
2. Leong AS, Milios J., Atypical fibroxanthoma of the skin: a clinicopathological and immunohistochemical study and a discussion of its histogenesis. Histopathology 1987; 11: 463.
3. Mirza B, Weedon D., Atypical fibroxanthoma: a clinicopathological study of 89 cases. Australas J Dermatol 2005; 46: 235.
4. Luzar B, Calonje E., Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review. J Cutan Pathol 2010; 37: 301.
5. Longacre TA, Smoller BR, Rouse RV., Atypical fibroxanthoma. Multiple immunohistologic profiles. Am J Surg Pathol 1993; 17: 1199.
6. Calonje E, Wadden C, Wilson-Jones E, Fletcher CD., Spindle-cell non-pleomorphic atypical fibroxanthoma: analysis of a series and delineation of a distinctive variant. Histopathology 1993; 22: 247.
7. Kim J, McNiff JM., Keloidal atypical fibroxanthoma: a case series. J Cutan Pathol 2009; 36: 535.
8. Patton A, Page R, Googe PB, King R., Myxoid atypical fibroxanthoma: a previously undescribed variant. J Cutan Pathol 2009; 36: 1177.
9. Rios-Martin JJ, Delgado MD, Moreno-Ramirez D, Garcia-Escudero A, Gonzalez-Campora R., Granular cell atypical fibroxanthoma: report of two cases. Am J Dermatopathol 2007; 29: 84.
10. Murali R, Palfreeman S., Clear cell atypical fibroxanthoma-report of a case with review of the literature. J Cutan Pathol 2006; 33: 343.
11. Crowson AN, Carlson-Sweet K, Macinnis C, et al., Clear cell atypical fibroxanthoma: a clinicopathologic study. J Cutan Pathol 2002; 29: 374.
12. Requena L, Sangueza OP, Sanchez Yus E, Furio V., Clear-cell atypical fibroxanthoma: an uncommon histopathologic variant of atypical fibroxanthoma. J Cutan Pathol 1997; 24: 176.
13. Wright NA, Thomas CG, Calame A, Cockerell CJ., Granular cell atypical fibroxanthoma: case report and review of the literature. J Cutan Pathol 2010; 37: 380.
14. Fussell JN, Cooke ER, Florentino F, Sheehan DJ., Atypical fibroxanthoma with keloidal collagen. Am J Dermatopathol 2010; 32: 713.
15. de Feraudy S, Mar N, McCalmont TH., Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol 2008; 32: 1111.
16. Smith-Zagone MJ, Prieto VG, Hayes RA, Timperman WW Jr, Diwan AH., HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report. J Cutan Pathol 2004; 31: 284.
17. Cai JP, Randall B., HMB-45 expression in a clear cell variant of atypical fibroxanthoma. J Cutan Pathol 2006; 33: 186.
18. Du J, Miller AJ, Widlund HR, Horstmann MA, Ramaswamy S, Fisher DE., MELAN-A/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol 2003; 163: 333.
19. Hornick JL, Fletcher CD., PEComa: what do we know so far? Histopathology 2006; 48: 75.
20. Bonetti F, Colombari R, Manfrin E, et al., Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast. Am J Clin Pathol 1989; 92: 491.
21. Busam KJ, Iversen K, Coplan KA, et al., Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 1998; 22: 57.
22. Wick MR, Swanson PE, Rocamora A., Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988; 15: 201.
23. Leinweber B, Hofmann-Wellenhof R, Kaddu S, McCalmont TH., Procollagen 1 and Melan-A expression in desmoplastic melanomas. Am J Dermatopathol 2009; 31: 173.
24. Busam KJ, Iversen K, Coplan KC, Jungbluth AA., Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001; 25: 197.